828
Views
15
CrossRef citations to date
0
Altmetric
Drug Evaluation

Colesevelam hydrochloride: a specifically engineered bile acid sequestrant

, MD, PhD & , MD
Pages 237-255 | Published online: 18 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Oluwayemisi Esan, Adie Viljoen & Anthony S. Wierzbicki. (2022) Colesevelam – a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia. Expert Opinion on Pharmacotherapy 23:12, pages 1363-1370.
Read now

Articles from other publishers (14)

Suriya P. Singh & Koneni V. Sashidhara. (2017) Lipid lowering agents of natural origin: An account of some promising chemotypes. European Journal of Medicinal Chemistry 140, pages 331-348.
Crossref
Adie Viljoen, Supriya Joshi & Anthony S. Wierzbicki. 2017. Textbook of Diabetes. Textbook of Diabetes 643 652 .
Negar Maghsoodi & Anthony S. Wierzbicki. (2016) Statin myopathy. Current Opinion in Cardiology 31:4, pages 417-425.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 285 315 .
Mfon Ewang-Emukowhate & Anthony S. Wierzbicki. (2013) Lipid-Lowering Agents. Journal of Cardiovascular Pharmacology and Therapeutics 18:5, pages 401-411.
Crossref
James Barnett, Adie Viljoen & Anthony S. Wierzbicki. (2013) The Need for Combination Drug Therapies in Patients with Complex Dyslipidemia. Current Cardiology Reports 15:8.
Crossref
Anthony S. Wierzbicki, Adie Viljoen, Timothy C. Hardman & Dimitri P. Mikhailidis. (2013) New therapies to reduce low-density lipoprotein cholesterol. Current Opinion in Cardiology 28:4, pages 452-457.
Crossref
Anthony S. Wierzbicki, Rosemary E. Clarke, Adie Viljoen & Dimitri P. Mikhailidis. (2012) Triglycerides. Current Opinion in Cardiology 27:4, pages 398-404.
Crossref
Kirsty J. McLeanMarcus Hans & Andrew W. Munro. (2012) Cholesterol, an essential molecule: diverse roles involving cytochrome P450 enzymes. Biochemical Society Transactions 40:3, pages 587-593.
Crossref
A. S. Wierzbicki, T. C. Hardman & A. Viljoen. (2012) New lipid-lowering drugs: an update. International Journal of Clinical Practice 66:3, pages 270-280.
Crossref
Ronald A. CodarioRonald A. Codario. 2011. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome 213 238 .
A. S. Wierzbicki. (2010) Comparing apples and pears: assessment of lipid-lowering therapies differentiated by side effects. International Journal of Clinical Practice 64:10, pages 1324-1326.
Crossref
Caroline M. Perry. (2010) Colesevelam. Pediatric Drugs 12:2, pages 133-140.
Crossref
Anthony S. Wierzbicki & Adie Viljoen. (2010) Hyperlipidaemia in Paediatric Patients. Drug Safety 33:2, pages 115-125.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.